Gender and comorbidity among individuals with opioid use disorders in the NESARC study.
about
Comparison of demographic characteristics and psychiatric comorbidity among methamphetamine-, heroin- and methamphetamine-heroin co- dependent males in Hunan, ChinaA review of treatment options for co-occurring methamphetamine use disorders and depressionEthnic disparities in accessing treatment for depression and substance use disorders in an integrated health planGender-related influences of parental alcoholism on the prevalence of psychiatric illnesses: analysis of the National Epidemiologic Survey on Alcohol and Related ConditionsSubtypes of nonmedical opioid users: results from the national epidemiologic survey on alcohol and related conditionsDistinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence.Prevalence of antisocial personality disorder among Chinese individuals receiving treatment for heroin dependence: a meta-analysisPrescription opioid misuse and mental health among young injection drug users.Feasibility of applying the life history calendar in a population of chronic opioid users to identify patterns of drug use and addiction treatment.30-year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California.Gender differences in physical and mental health outcomes among an aging cohort of individuals with a history of heroin dependenceSuicidal ideation and suicide attempt across stages of nonmedical prescription opioid use and presence of prescription opioid disorders among U.S. adults.Latent classes of heroin and cocaine users predict unique HIV/HCV risk factorsPersistent Adaptations in Afferents to Ventral Tegmental Dopamine Neurons after Opiate WithdrawalProfiles of psychiatric disorders among heroin dependent individuals in Changsha, China.The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findingsTreating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data.Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.A history of chronic morphine exposure during adolescence increases despair-like behaviour and strain-dependently promotes sociability in abstinent adult micePast year non-medical opioid use and abuse and PTSD diagnosis: Interactions with sex and associations with symptom clusters.Gender differences in a clinical trial for prescription opioid dependenceInfluence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics.Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status.Comparisons of Cocaine-Only, Opioid-Only, and Users of Both Substances in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy.Substance Use and Associated Health Conditions throughout the Lifespan.Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence.Pathological and problem gambling in substance use treatment: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).Substance use and women's health.Impact of lifetime psychiatric diagnosis on long-term retention and survival of former opiate addicts in methadone maintenance treatment.Prevalence of psychiatric disorders among heroin users who received methadone maintenance therapy in Taiwan.Prevalence and key covariates of non-medical prescription opioid use among the general secondary student and adult populations in Ontario, Canada.Prevalence, Diagnosis, and Treatment Rates of Mood Disorders among Opioid Users under Criminal Justice Supervision.Clinical characteristics of poly-drug abuse among heroin dependents and association with other psychopathology in compulsory isolation treatment settings in China.Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China.Dissociation of heroin-induced emotional dysfunction from psychomotor activation and physical dependence among inbred mouse strains.Intervening with Women in Jail around Alcohol and Substance Abuse During Preparation for Community Reentry
P2860
Q33668115-D00DDE7D-7946-45AF-8D9D-C5BA369BB2BAQ33904064-D2402522-9DF5-48F1-A939-DF2ACB4716EFQ34070837-4CD5DAD5-C5ED-49E3-ABC4-2F59FC58242BQ34179898-49E2639A-0B6C-4A70-A6AD-4D772FF481A1Q34258698-E2D2DF2D-0B81-48A4-A443-97F25337BA76Q34393118-D75B27D1-8F04-416B-888C-069CE3A3A6DAQ34590019-2C0E1F55-8016-4AB7-8F42-B653439FBC85Q34674284-40BB447F-0C59-4077-8D3E-3F87A5B74233Q34710775-DC7F4B37-02DB-44AB-AF24-D2D616C2D826Q35167166-C7454818-5747-434A-B62F-DBD8664DA8A2Q35672907-20302C65-4DFD-4877-9F60-A9F608576212Q35764024-78DEA8B2-89A8-4E41-87E6-872B1BED7E51Q35842949-F20706C5-EC58-4C74-9870-EF22161E9E23Q35851528-DB08BA89-9704-48AD-B964-DCE2D5BEDD61Q36173346-E2DB0205-E2C2-496A-B501-A98D44F8ED92Q36200016-5DBE4DC0-E25F-4CC9-BC29-0558B70706C7Q36367544-87F6C7DE-75F0-4E40-A879-8DE13440B6F6Q36441841-EFB542FC-AAFE-4D39-B522-05C5B26D75C5Q36674787-9BE43443-4CF7-41F1-B317-5B79DDB916FBQ36730877-99700D5E-36C4-4B61-9FC0-15DE1E1FFB44Q36767128-FB5793B0-BC34-4B18-8D86-EF2BA13C625AQ36966035-CABC1696-916F-4154-B3D8-1C47B9EA0E8AQ37188602-88CB31C5-FE8A-4773-B9EF-E54801B09DEEQ37396559-36C66970-5998-4C71-98AF-2B0753E217A7Q37724712-C1DFD8AE-EE5A-4CF4-8F2D-9C39264D002AQ37730029-D6B938F8-A115-403B-8466-6AFCFCEE0EB9Q41505543-6742E93A-9FF3-4774-A157-0DDDD22D44BEQ41756376-90204C1E-8016-405F-950C-1C29BFDE591BQ43090976-CE6C63BC-6A21-45C5-8421-B21046583B25Q44121877-24C19658-0193-4184-821A-0DA933E3C7AEQ44156969-8359A370-AAC1-4D75-98C6-FFD251AD0B2AQ44337464-1C38AE57-E7C8-4E6A-957D-C6BF5923630BQ47555908-2562FA48-CDEA-4F3B-92DC-B38B117BF13EQ47597971-3CAC0860-089B-445E-8B8F-3D5068806537Q47768718-E7563126-4E37-46AB-9237-BE77EC643B81Q47775874-24329DCF-3B2B-4D37-9F37-F1B2CD77293EQ58247332-A0910C31-519C-4097-8BC2-2E819F72B98B
P2860
Gender and comorbidity among individuals with opioid use disorders in the NESARC study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gender and comorbidity among individuals with opioid use disorders in the NESARC study.
@en
Gender and comorbidity among individuals with opioid use disorders in the NESARC study.
@nl
type
label
Gender and comorbidity among individuals with opioid use disorders in the NESARC study.
@en
Gender and comorbidity among individuals with opioid use disorders in the NESARC study.
@nl
prefLabel
Gender and comorbidity among individuals with opioid use disorders in the NESARC study.
@en
Gender and comorbidity among individuals with opioid use disorders in the NESARC study.
@nl
P2093
P2860
P1433
P1476
Gender and comorbidity among individuals with opioid use disorders in the NESARC study.
@en
P2093
Alison A Moore
Christine E Grella
Mitchell P Karno
Noosha Niv
Umme S Warda
P2860
P304
P356
10.1016/J.ADDBEH.2009.01.002
P577
2009-01-30T00:00:00Z